Early ultrasonographic markers of atherosclerosis in patients with familial Mediterranean fever

被引:53
作者
Sari, Ismail
Karaoglu, Oguzhan
Can, Gercek
Akar, Servet
Gulcu, Aytac
Birlik, Merih
Akkoc, Nurullah
Tunca, Mehmet
Goktay, Yigit
Onen, Fatos [1 ]
机构
[1] Dokuz Eylul Univ, Tip Fak, Ic Hastaliklari ABD, Immunol Romatol BD, TR-35340 Izmir, Turkey
[2] Dokuz Eylul Univ, Sch Med, Dept Internal Med, Div Rheumatol, TR-35340 Izmir, Turkey
[3] Dokuz Eylul Univ, Sch Med, Dept Radiol, TR-35340 Izmir, Turkey
[4] Dokuz Eylul Univ, Sch Med, Dept Internal Med, Izmir, Turkey
关键词
arteriosclerosis; familial Mediterranean fever; ultrasonography;
D O I
10.1007/s10067-006-0529-2
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Systemic inflammation plays an important role in the development of atherosclerosis (AS). The aim of this study was to evaluate the presence of early AS in patients with familial Mediterranean fever (FMF) that is characterized by recurrent inflammatory attacks of serositis. Sixty-one FMF patients (30 Male/31 Female; 31.5 [18-54] years) and 31 healthy controls (16 Male/15 Female; 31 [22-58] years) were studied. All FMF patients were on regular daily colchicine treatment and during attack-free periods. Both the FMF patients and controls with a history of diabetes mellitus (DM), hypertension, and hyperlipidemia were excluded. Body mass index (BMI) was calculated. Serum lipids, C-reactive protein (CRP), and erythrocyte sedimentation rate (ESR) were assessed. Two-hour oral glucose tolerance test was performed to rule out DM and glucose intolerance. To investigate early AS "endothelium-dependent flow-mediated dilatation (FMD%)," "nitroglycerin-induced endothelium-independent peripheral vasodilatation (NTG%)," and intima-media thickness (IMT) of common carotid arteries (CCA) were measured by ultrasonograpy. The median disease duration for FMF patients was 16 (1-45) years. Age, sex, BMI, smoking status, and serum lipids were comparable in patients and controls (p > 0.05). However, ESR and standard CRP were significantly higher in the patients group (p < 0.05). There were no differences in the measurements of right, left, and averaged IMT of CCA between patients and controls ([0.49 vs 0.5], [0.51 vs 0.52] and [0.5 vs 0.51]; p > 0.05, respectively). None of the subjects had carotid artery plaques. FMD% and NTG% were also similar in patients and controls group ([18.2 vs 20.6] and [24.2 vs 22.5]; p > 0.05, respectively). This study suggests that the markers of early AS are not impaired in FMF patients on regular daily colchicine treatment.
引用
收藏
页码:1467 / 1473
页数:7
相关论文
共 36 条
[1]  
Agewall Stefan, 2003, Current Vascular Pharmacology, V1, P107, DOI 10.2174/1570161033476745
[2]  
Akdogan A, 2005, ANN RHEUM DIS, V64, P542
[3]  
Bacon P. A., 2002, Autoimmunity Reviews, V1, P338, DOI 10.1016/S1568-9972(02)00100-3
[4]   Mechanism of the anti-inflammatory effect of colchicine in rheumatic diseases: a possible new outlook through microarray analysis [J].
Ben-Chetrit, E ;
Bergmann, S ;
Sood, R .
RHEUMATOLOGY, 2006, 45 (03) :274-282
[5]   Endothelial dysfunction precedes C-fiber abnormalities in primary (AL) amyloidosis [J].
Berghoff, M ;
Kathpal, M ;
Khan, F ;
Skinner, M ;
Falk, R ;
Freeman, R .
ANNALS OF NEUROLOGY, 2003, 53 (06) :725-730
[6]  
Bilginer Y, 2006, ANN RHEUM DIS, V65, P100
[7]   Endothelial cell activation, injury, damage and dysfunction: separate entities or mutual terms? [J].
Blann, AD .
BLOOD COAGULATION & FIBRINOLYSIS, 2000, 11 (07) :623-630
[8]   Patterns of active and passive smoking, and associated factors, in the South-east Anatolian Project (SEAP) region in Turkey [J].
Bozkurt, AI ;
Sahinöz, S ;
Özçirpici, B ;
Özgür, S ;
Sahinöz, T ;
Acemoglu, H ;
Saka, G ;
Ceylan, A ;
Palanci, Y ;
Ilçin, E ;
Akkafa, F .
BMC PUBLIC HEALTH, 2006, 6 (1)
[9]   COLCHICINE ALTERS THE QUANTITATIVE AND QUALITATIVE DISPLAY OF SELECTINS ON ENDOTHELIAL-CELLS AND NEUTROPHILS [J].
CRONSTEIN, BN ;
MOLAD, Y ;
REIBMAN, J ;
BALAKHANE, E ;
LEVIN, RI ;
WEISSMANN, G .
JOURNAL OF CLINICAL INVESTIGATION, 1995, 96 (02) :994-1002
[10]   Low grade inflammation and coronary heart disease: prospective study and updated meta-analyses [J].
Danesh, J ;
Whincup, P ;
Walker, M ;
Lennon, L ;
Thomson, A ;
Appleby, P ;
Gallimore, JR ;
Pepys, MB .
BMJ-BRITISH MEDICAL JOURNAL, 2000, 321 (7255) :199-204